Company
Duearity AB
Headquarters: Malmo, Sweden
Employees: 1
CEO: Mr. Fredrik Westman
Market Cap
kr58.5 Million
SEK as of Jan. 1, 2024
US$5.8 Million
Top Competitors by Market Capitalization
Industry: Medical Devices
| Company | Market Cap (USD) |
|---|---|
| Abbott | $192.67 B |
| Stryker Corporation | $113.24 B |
| Medtronic | $111.60 B |
| Boston Scientific Corporation | $85.22 B |
| Shenzhen Mindray Bio-Medical Electronics Co. Ltd | $49.33 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Detailed Description
Duearity AB (publ), a medical technology company, engages in the development of Tinearity, a tinnitus aid. The company's Tinearity contains a small sound element that generates white noise directly into the ear via the skull. It also develops Tinearity AI, an artificial intelligence-based solution that would help people suffering from or bothered by tinnitus to take command and master their symptoms. The company was incorporated in 2020 and is based in Malmö, Sweden.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Stocks & Indices
Duearity AB has the following listings and related stock indices.
Stock: OMX: DEAR wb_incandescent